Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 346–360 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5868 HMBS Gene (Porphyria Acute Intermittent) Genetic Test This genetic test evaluates the hydroxymethylbilane synthase (HMBS) gene for pathogenic variants associated with acute intermittent porphyria (AIP). It provides a comprehensive ana...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HMBS gene sequence", "Pathogenic variants in HMBS gene"] Parameters [] Preparation ["Fasting is not required", "Avoid alcohol for 24 hours before sample collection"] Indications ["Suspected acute intermittent porphyria (AIP)", "Family history of AIP", "Recurrent unexplained acute attacks"] Measurement technique Confirm with laboratory Codes LOINC: 21626-1 ICD-10: E80.21 Clinical summary This genetic test evaluates the hydroxymethylbilane synthase (HMBS) gene for pathogenic variants associated with acute intermittent porphyria (AIP). It provides a comprehensive analysis of the gene to confirm or rule out the diagnosis.
TEST-424 Horse DNA Test (Equine DNA Detection) This test detects the presence of equine (horse) DNA in a human blood sample.	Peripheral whole blood (EDTA)	10 business days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Equine DNA sequences"] Parameters [] Preparation ["Inform team if antibiotic or antiviral therapy within last 7 days"] Indications ["Suspected accidental consumption of horse meat", "Food fraud investigations", "Health anxiety related to dietary contamination", "Legal verification purposes"] Measurement technique Confirm with laboratory Codes LOINC: 57721-3 ICD-10: Z03.89 Clinical summary This test detects the presence of equine (horse) DNA in a human blood sample.
TEST-3416 HOXA13 Gene Hand‑Foot‑Uterus Syndrome Genetic Test This genetic test identifies pathogenic variants in the HOXA13 gene associated with Hand-Foot-Uterus Syndrome.	Whole blood (2‑3 mL EDTA) or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HOXA13 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% for SNVs/indels"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (NGS) with full bioinformatic annotation"}] Preparation ["Pre-test genetic counselling session required", "Clinical history mandatory", "Parental consent required for minors"] Indications ["Individuals with clinical features suggestive of Hand-Foot-Uterus Syndrome", "Family members of individuals diagnosed with Hand-Foot-Uterus Syndrome", "Confirmation of molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94076-2 ICD-10: Q87.2, Q87.8, N97.9 Clinical summary This genetic test identifies pathogenic variants in the HOXA13 gene associated with Hand-Foot-Uterus Syndrome.
TEST-2258 HOXD13 Gene Syndactyly Type 1 Genetic Test This test evaluates the HOXD13 gene for pathogenic variants associated with non-syndromic syndactyly type 1.	Whole blood (EDTA) or saliva (Oragene® kit)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HOXD13 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)"] Parameters [] Preparation ["Complete a pre-test genetic counseling appointment", "Fasting is not required", "Continue prescribed medications unless directed otherwise by your physician"] Indications ["Clinical suspicion of non-syndromic syndactyly type 1", "Confirmation of clinical diagnosis", "Genetic counseling for affected families", "Carrier screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 78043-4 ICD-10: Q70.0 Clinical summary This test evaluates the HOXD13 gene for pathogenic variants associated with non-syndromic syndactyly type 1.
TEST-3320 HP Gene Ahaptoglobinemia Genetic Test This genetic test identifies pathogenic variants in the haptoglobin (HP) gene to diagnose congenital ahaptoglobinemia.	Whole Blood (EDTA) or Extracted DNA	10–14 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Haptoglobin (HP) gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "Do not discontinue prescribed medications without physician instruction"] Indications ["Suspected congenital ahaptoglobinemia", "Family history of ahaptoglobinemia", "Unexplained hemolytic anemia or iron deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E88.09 Clinical summary This genetic test identifies pathogenic variants in the haptoglobin (HP) gene to diagnose congenital ahaptoglobinemia.
TEST-3689 HPS3 Gene (Hermansky‑Pudlak Syndrome Type 3) Genetic Test This genetic test evaluates the HPS3 gene for mutations associated with Hermansky-Pudlak syndrome type 3.	Blood, extracted DNA, or one drop blood on FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HPS3 gene sequence", "Mutations (point mutations, small indels, copy-number variants)"] Parameters [] Preparation ["Provide detailed clinical history", "Mandatory genetic counselling session required"] Indications ["Clinical suspicion of Hermansky-Pudlak syndrome type 3", "Family history of HPS3 mutations", "Carrier screening in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 82939-1 ICD-10: E70.31 Clinical summary This genetic test evaluates the HPS3 gene for mutations associated with Hermansky-Pudlak syndrome type 3.
TEST-3659 HPS4 Gene Hermansky-Pudlak Syndrome Type 4 Genetic Test This genetic test evaluates the HPS4 gene for pathogenic variants associated with Hermansky-Pudlak syndrome type 4.	Peripheral Whole Blood (EDTA Tube) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HPS4 gene sequence", "Copy Number Variants (CNVs) in HPS4 gene"] Parameters [] Preparation [] Indications ["Individuals presenting with oculocutaneous albinism", "Individuals with unexplained bleeding tendency", "Individuals with pulmonary fibrosis"] Measurement technique Confirm with laboratory Codes LOINC: 81262-3 ICD-10: E70.331 Clinical summary This genetic test evaluates the HPS4 gene for pathogenic variants associated with Hermansky-Pudlak syndrome type 4.
TEST-2933 HRAS Gene Costello Syndrome Genetic Test This test identifies pathogenic variants in the HRAS gene associated with Costello syndrome.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HRAS gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session required", "Obtain informed consent", "Draw a three-generation pedigree"] Indications ["Clinical suspicion of Costello syndrome", "Family history of Costello syndrome", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 95721-2 ICD-10: Q87.89, Z13.79, Z82.79 Clinical summary This test identifies pathogenic variants in the HRAS gene associated with Costello syndrome.
TEST-6108 HSD11B2 Gene (Apparent Mineralocorticoid Excess) Genetic Test This genetic test sequences the entire HSD11B2 gene to identify pathogenic variants causing Apparent Mineralocorticoid Excess (AME), a rare form of hypertension.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HSD11B2 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Continue prescribed medications unless advised otherwise by physician", "Disclose all supplements and medications during pre-test counselling"] Indications ["Suspected Apparent Mineralocorticoid Excess (AME)", "Early-onset hypertension with hypokalemia", "Family history of monogenic hypertension"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E24.3 Clinical summary This genetic test sequences the entire HSD11B2 gene to identify pathogenic variants causing Apparent Mineralocorticoid Excess (AME), a rare form of hypertension.
TEST-3941 HSD17B10 Gene (17-Beta Hydroxysteroid Dehydrogenase X Deficiency) Genetic Test This genetic test evaluates the HSD17B10 gene for mutations associated with 17-Beta Hydroxysteroid Dehydrogenase X Deficiency.	Whole blood (EDTA), Extracted DNA, or FTA Card (dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HSD17B10 gene sequence", "Pathogenic variants"] Parameters [] Preparation ["Provide comprehensive clinical history", "Provide a three-generation pedigree chart"] Indications ["Suspected 17-beta hydroxysteroid dehydrogenase X deficiency", "Carrier detection", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 82311-7 ICD-10: E71.1 Clinical summary This genetic test evaluates the HSD17B10 gene for mutations associated with 17-Beta Hydroxysteroid Dehydrogenase X Deficiency.
TEST-2893 HSD17B4 Gene D-Bifunctional Protein Deficiency Genetic Test This test identifies pathogenic variants in the HSD17B4 gene, confirming a diagnosis of D-bifunctional protein deficiency.	Peripheral whole blood or FTA card (dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HSD17B4 gene", "Ability to break down very-long-chain fatty acids"] Parameters [] Preparation ["No specific fasting required.", "Inform the phlebotomist of any medications."] Indications ["Infants and children with hypotonia and seizures", "Suspicion of a peroxisomal disorder", "Family history of D-bifunctional protein deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 82213-8 ICD-10: E71.510 Clinical summary This test identifies pathogenic variants in the HSD17B4 gene, confirming a diagnosis of D-bifunctional protein deficiency.
TEST-4061 HTRA1 Gene (CARASIL) Genetic Test This test identifies biallelic pathogenic variants in the HTRA1 gene, confirming a diagnosis of CARASIL.	Peripheral Whole Blood or Dried Blood Spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HTRA1 gene mutations", "Biallelic pathogenic variants"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected CARASIL diagnosis", "Family history of early-onset stroke or vascular dementia", "Evaluation of unexplained cerebral small vessel disease"] Measurement technique Confirm with laboratory Codes LOINC: 93721-0 ICD-10: I67.8 Clinical summary This test identifies biallelic pathogenic variants in the HTRA1 gene, confirming a diagnosis of CARASIL.
TEST-1705 Huntington Disease Mutation Detection Test This test detects and quantifies the CAG trinucleotide repeat expansion in the HTT gene, which is the genetic cause of Huntington disease.	Peripheral Whole Blood (Lavender-top EDTA Tube)	10 Working Days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion in the HTT gene", "Exact CAG repeat length (normal, intermediate, pathogenic)"] Parameters [{"name": "CAG Repeat Length", "reference_range": "=40 (Pathogenic)"}] Preparation [] Indications ["Confirm diagnosis in symptomatic individuals", "Predictive testing for asymptomatic adults with family history", "Presymptomatic screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G10, Z15.89, Z82.3 Clinical summary This test detects and quantifies the CAG trinucleotide repeat expansion in the HTT gene, which is the genetic cause of Huntington disease.
TEST-4896 HUWE1 Gene Sequencing Test for X-Linked Syndromic Intellectual Disability (Turner Type) This test evaluates the HUWE1 gene for pathogenic variants associated with X-linked syndromic intellectual disability (Turner type). It identifies specific genetic mutations causin...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HUWE1 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation [] Indications ["Diagnosis of X-linked syndromic intellectual disability", "Carrier screening for at-risk female relatives", "Family planning and recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94222-1 ICD-10: F78 Clinical summary This test evaluates the HUWE1 gene for pathogenic variants associated with X-linked syndromic intellectual disability (Turner type). It identifies specific genetic mutations causing the condition.
TEST-5729 IARS2 Gene Comprehensive Genetic Test This test sequences the entire IARS2 gene to identify mutations causing a rare syndrome characterized by congenital cataracts, growth hormone deficiency, sensory neuropathy, hearin...	Peripheral Whole Blood or FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["IARS2 gene sequence", "Pathogenic variants (point mutations, indels, CNVs)"] Parameters [] Preparation ["Clinical consultation with a qualified physician is mandatory prior to testing.", "Physician clearance required if patient is receiving anticoagulation therapy."] Indications ["Clinical suspicion of IARS2-related disorder", "Early-onset cataracts", "Growth hormone deficiency", "Sensorineural hearing loss", "Radiographic skeletal abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.89 Clinical summary This test sequences the entire IARS2 gene to identify mutations causing a rare syndrome characterized by congenital cataracts, growth hormone deficiency, sensory neuropathy, hearing loss, and skeletal dysplasia.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.